Drug intelligence / Profile preview

aleurites moluccanus extract

Development stage
Preclinical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Aleurites moluccanus extract is a botanical extract derived from the leaves of the Aleurites moluccanus (candlenut) tree. It is primarily investigated in preclinical research for its anti-inflammatory, analgesic, and disease-modifying properties, particularly in the context of rheumatoid arthritis and neuropathic pain. The extract is typically standardized to contain the flavonoid 2″-O-rhamnosylswertisin, which is considered its main active constituent. In experimental models, it has demonstrated the ability to reduce mechanical hypersensitivity, paw edema, and joint damage, including bone erosion and cartilage degradation. Its mechanism of action involves the modulation of opioid, dopaminergic, and oxidonitrergic pathways, as well as the inhibition of prostaglandin E2 (PGE2) and reduction of pro-inflammatory cytokines like IL-1β.

Other names
aleurites moluccana extractcandlenut tree extractA. moluccanus extract
02

Targets

DRD (Dopamine receptors)MOR (Mu opioid receptor)PGE2 (Prostaglandin E2)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on aleurites moluccanus extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aleurites moluccanus extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call